January 17, 2023
2 min watch
Save
VIDEO: ViaLase’s femtosecond laser shows positive safety, efficacy data
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Shawn O’Neil of ViaLase discusses positive 24-month safety and efficacy data for the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.
The laser showed no adverse events at 2 years, as well as a median IOP lowering of 32% in a case series of 17 eyes, he said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
O’Neill is chief commercial officer of ViaLase.
Read more about